Acentra Health (formerly Kepro) Earns URAC Disease Management Accreditation for Adhering to Care Standards That Prevent and Control Chronic Disease
19 Dicembre 2023 - 2:46PM
Acentra Health, a leading provider of clinical services and
technology solutions to government healthcare agencies, announced
today that Kepro (which rebranded as Acentra Health in June 2023
following its merger with CNSI) has received full accreditation
from URAC in Disease Management. The prestigious accreditation
demonstrates Acentra Health’s dedication in adhering to rigorous
standards of quality and safety for preventing and controlling
chronic diseases in individuals with diagnosed conditions.
URAC is the nation’s leading independent accrediting
organization committed to promoting health care quality and patient
safety through its accreditation and certification programs. URAC
develops its evidence-based standards in collaboration with a wide
array of stakeholders and industry experts.
“Earning URAC’s Disease Management Accreditation is a testament
to Acentra Health’s commitment to excellence in helping our clients
deliver services that support individuals in effectively managing
their chronic diseases and live healthier lives,” said Acentra
Health CEO Todd Stottlemyer. “URAC accreditation is a comprehensive
process, and we are proud to have received this distinction yet
again.”
Organizations that receive URAC’s Disease Management
accreditation follow evidence-based standards for the prevention,
early detection, and timely intervention of chronic diseases. These
practices lead to more effective utilization of services and
medication adherences, which helps reduce emergency room visits and
hospitalizations. Acentra Health’s experienced team of clinical
reviewers, case managers, and health education specialists conduct
in-person and telephonic outreach to education patients about their
chronic disease, like asthma or diabetes, and develop strategies to
effectively self-manage their condition. The team also provides
regular reminders about wellness and preventive screenings via
telephone and a quarterly e-newsletter.
URAC’s Disease Management accreditation is valid for three years
and was awarded to Acentra Health’s Nashville-based office
location. The company also holds URAC accreditations, earned
through Kepro, in Case Management, for its excellence in care
coordination, in Health Utilization Management, for ensuring
individuals receive appropriate quality and cost-effective care in
the right setting, and Independent Review Organization, validating
Acentra Health as a fair and impartial third-party medical reviewer
for patients and physicians.
About Acentra Health
Acentra Health, formed by the merger of industry leaders CNSI
and Kepro, combines public sector knowledge, clinical expertise,
and technological ingenuity to modernize the healthcare experience
for state and federal partners and their priority populations. From
designing and developing advanced claims, encounter, and provider
solutions that drive efficiency and cost savings to delivering
clinically focused service models for care management and quality
oversight, Acentra Health is accelerating better outcomes. Acentra
Health is backed by Carlyle (NASDAQ: CG), a global investment firm.
Visit acentra.com.
About URAC
Founded in 1990 as a non-profit organization, URAC is the
independent leader in promoting health care quality and patient
safety through renowned accreditation programs. URAC develops its
evidence-based standards in collaboration with a wide array of
stakeholders and industry experts. The company’s portfolio of
accreditation and certification programs spans the health care
industry, addressing health care management and operations,
pharmacies, telehealth, health plans, medical practices and more.
URAC accreditation is a symbol of excellence for organizations to
showcase their validated commitment to quality and accountability.
urac.org.
Media Contact:
Janice Moore
VP, Corporate Communications
703-214-3552
Grafico Azioni Carlyle (NASDAQ:CG)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Carlyle (NASDAQ:CG)
Storico
Da Giu 2023 a Giu 2024